ALZN Stock Analysis: Buy, Sell, or Hold?
ALZN - Alzamend Neuro, Inc. Common Stock
$1.20
-0.09 (-6.98%)
▼
5d:
-1.64%
30d:
+4.35%
90d:
-20.0%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Jul 28, 2026
29d
Get Alerted When ALZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALZN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ALZN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALZN is currently trading at $1.20, which is considered fair relative to its 30-day fair value range of $1.13 to $1.26.
Technical Outlook: Technically, ALZN is in a strong downtrend. Immediate support is located at $1.13, while resistance sits at $1.37. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ALZN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+1983.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALZN is in a strong downtrend. Immediate support is located at $1.13, while resistance sits at $1.37. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ALZN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+1983.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.13 -
$1.26
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 1983.3% below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$1.13 -
$1.26
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.13
Resistance Level
$1.37
Current Trend
Strong Downtrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.46
Wall Street Target
$25.00
(+1983.3%)
Share & Embed Analysis
Last updated: June 28, 2026 7:05 AM ET
Data refreshes hourly during market hours. Next update: 8:05 AM
Data refreshes hourly during market hours. Next update: 8:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALZN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Milton C Ault III
BUY
108388 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 52 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 55 HOLD |
